Alloplex Biotherapeutics is pleased to announce that Scientific Founder and CEO, Dr. Frank Borriello, will be a speaker at the PDDP Summit in Boston, June 8-9, 2026.
As Alloplex advances its innovative technology platform, Dr. Borriello welcomes the opportunity to meet with potential collaborators and partners focused on the next generation of cell therapy. We are seeking to engage with groups interested in a wholly differentiated approach with broad applications across oncology (phase 2 ready), autoimmunity (phase 1 ready), and longevity.
“The drug discovery industry in Boston stands at the forefront of global innovation, playing a pivotal role in advancing pharmaceutical research and development. Boston’s robust ecosystem, characterized by a concentration of world-class academic institutions, cutting-edge biotech companies, and a collaborative spirit, fosters an environment conducive to groundbreaking discoveries. Boston proudly serves as the global epicenter for the foremost cluster of biotech and life science enterprises. Now, envision a more fitting locale to engage with the trailblazers leading the charge in groundbreaking research within the realms of Drug Discovery & Preclinical Research.
The 28th Precision in Drug Discovery & Preclinical Summit (Boston, USA), PDDP gathering will showcase the progress and latest research trends that include new compounds, artificial intelligence & Machine learning, drug design, synthesis methods, and technologies that advance the science of leaders in the pharma-biotech and academic spaces. With an innovation-focused agenda and pre-scheduled meetings between potential collaborators and a host of reliable service providers, the summit is designed to help attendees find solutions to their most pressing research challenges in 2026 and beyond.”
To register, visit: precision-drug-discovery-preclinical-summit-boston-usa